Literature DB >> 11796503

Regulation of IGF-I mRNA and signal transducers and activators of transcription-3 and -5 (Stat-3 and -5) by GH in C2C12 myoblasts.

Robert A Frost1, Gerald J Nystrom, Charles H Lang.   

Abstract

GH and IGF-I are critical hormones for the regulation of longitudinal growth and the maintenance of lean body mass in humans. The regulation of IGF-I expression by GH in hepatocytes is well documented; however less is known about the regulation of IGF-I in peripheral tissues such as muscle. We have examined the regulation of IGF-I mRNA by GH and IGF-I in C2C12 myoblasts. GH stimulated the accumulation of IGF-I mRNA dose- and time-dependently. An elevation of IGF-I mRNA was observed with GH doses as low as 0.75 ng/ml and after exposure to GH for as little as 1 h, and the increase required ongoing transcription and translation. GH applied in a pulsatile fashion for 10 min followed by an 8-h interpulse interval increased IGF-I mRNA to a greater extent than continuous exposure. GH stimulated tyrosine phosphorylation of the GH receptor, signal transducer and activator of transcription-3 (Stat3), and Stat5. Stat5 was resistant to additional phosphorylation if cells were given a GH pulse within 2 h of a previous GH exposure. The refractory period lasted for 4 h, and cells could be maximally stimulated again after 6 h. Stat3 phosphorylation was also enhanced in cells that were allowed to recover from a previous application of GH. The tyrosine kinase inhibitors, genistein, PP1, and AG-490, and the MAPK kinase inhibitor, PD98059, did not block Stat3 or Stat5 phosphorylation. In contrast, WHI-P154, a Janus kinase-3 inhibitor, dose-dependently prevented Stat3, but not Stat5, phosphorylation. GH-inducible nuclear transport of Stat3 was likewise inhibited by WHI-P154. Most importantly, GH-dependent IGF-I mRNA expression was inhibited by WHI-P154. In contrast, IGF-I mRNA expression was inhibited by IGF-I peptide, and the effect of IGF-I was dominant over that of GH. IGF-I mRNA was regulated by both PI3K and MAPK signal transduction pathways, but IGF-I peptide signaled predominantly through a wortmannin-sensitive pathway to down-regulate its own mRNA. Our data suggest that Janus kinases (Jak2 or Jak3) and their downstream targets (Stat3 and Stat5) may play important roles in the expression of IGF-I mRNA and the myoblast response to GH. In addition, C2C12 cells appear to be a good model system to examine GH regulation of Janus kinase/Stat signaling and the regulation of IGF-I mRNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796503     DOI: 10.1210/endo.143.2.8641

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  23 in total

1.  Muscle IGF-I Ea, MGF, and myostatin mRNA expressions after compensatory overload in hypophysectomized rats.

Authors:  Akihiko Yamaguchi; Takahiko Fujikawa; Seita Shimada; Isao Kanbayashi; Masaru Tateoka; Hideaki Soya; Hidekatsu Takeda; Isao Morita; Kunio Matsubara; Toshihiro Hirai
Journal:  Pflugers Arch       Date:  2006-08-29       Impact factor: 3.657

Review 2.  Body size regulation and insulin-like growth factor signaling.

Authors:  Seogang Hyun
Journal:  Cell Mol Life Sci       Date:  2013-03-19       Impact factor: 9.261

3.  Mechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblasts.

Authors:  Jason L S Leen; Angelo Izzo; Chandani Upadhyay; Katherine J Rowland; Philip E Dubé; Steven Gu; Scott P Heximer; Christopher J Rhodes; Daniel R Storm; P Kay Lund; Patricia L Brubaker
Journal:  Endocrinology       Date:  2010-12-15       Impact factor: 4.736

4.  Transcriptional regulation of the IGF signaling pathway by amino acids and insulin-like growth factors during myogenesis in Atlantic salmon.

Authors:  Neil I Bower; Ian A Johnston
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

Review 5.  Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives.

Authors:  Y Rolland; S Czerwinski; G Abellan Van Kan; J E Morley; M Cesari; G Onder; J Woo; R Baumgartner; F Pillard; Y Boirie; W M C Chumlea; B Vellas
Journal:  J Nutr Health Aging       Date:  2008 Aug-Sep       Impact factor: 4.075

6.  Carla Task Force on Sarcopenia: propositions for clinical trials.

Authors:  G Abellan van Kan; E André; H A Bischoff Ferrari; Y Boirie; G Onder; M Pahor; P Ritz; Y Rolland; C Sampaio; S Studenski; M Visser; B Vellas
Journal:  J Nutr Health Aging       Date:  2009-10       Impact factor: 4.075

Review 7.  Regulation of muscle mass by growth hormone and IGF-I.

Authors:  C P Velloso
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

8.  Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2- and DDIT3-mediated mechanism.

Authors:  Silvia Zecchini; Matteo Giovarelli; Cristiana Perrotta; Federica Morisi; Thierry Touvier; Ilaria Di Renzo; Claudia Moscheni; Maria Teresa Bassi; Davide Cervia; Marco Sandri; Emilio Clementi; Clara De Palma
Journal:  Autophagy       Date:  2018-09-10       Impact factor: 16.016

9.  Phosphorylation of the JAK2-STAT5 pathway in response to acute aerobic exercise.

Authors:  Leslie A Consitt; Laurie Wideman; Matthew S Hickey; Ron F Morrison
Journal:  Med Sci Sports Exerc       Date:  2008-06       Impact factor: 5.411

10.  Stimulation of muscle protein synthesis by somatotropin in pigs is independent of the somatotropin-induced increase in circulating insulin.

Authors:  Fiona A Wilson; Renán A Orellana; Agus Suryawan; Hanh V Nguyen; Asumthia S Jeyapalan; Jason Frank; Teresa A Davis
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-06       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.